With many sufferers unaware they’ve dry mouth, privately held Ok Prescription drugs has launched the “first ever” in-office Personalised Xerostomia Protocol (PXP) instrument to help dentists in figuring out and managing the situation.
Moderately than providing a one-size-fits-all answer, the PXP is designed to be used with each affected person at each appointment. It supplies clear tips and an easy-to-follow methodology to establish and educate sufferers on dry mouth signs. Crucially, the PXP additionally facilitates re-evaluating remedy primarily based on sufferers’ evolving well being wants.
‘Silent pandemic’
“Paradoxically, many people affected by dry mouth stay unaware of their situation,” mentioned Melissa Turner, BASDH, RDHEP, EFDA, a number one registered dental hygienist and dental model strategist. “Xerostomia has turn out to be a silent pandemic that may be detrimental to our sufferers’ systemic well being, typically diminishing their high quality of life.”
The PXP instrument was developed in partnership with Turner, who emphasised its position in heightening consciousness amongst dental professionals and sufferers. “The PXP seeks to propel the dialog ahead and allow us to face collectively for xerostomia aid,” she added.
Rise in dry mouth instances
The protocol’s launch comes amid a documented rise in dry mouth instances, a situation as soon as primarily related to the aged or disease-related xerostomia. Based on the Faculty of Dental Hygienists of Ontario, prevalence is at the least 20 per cent within the common inhabitants, with elevated prevalence in females (as much as 30 per cent) and the aged (as much as 50 per cent). In america, xerostomia impacts an estimated 30 per cent of sufferers older than 65 years and as much as 40 per cent of sufferers older than 80 years, in line with the American Dental Affiliation. Moreover, the rise can be resulting from unwanted effects of most medicines together with trending weight reduction medicine, use of CPAP machines, and the rising use of marijuana.
What impressed the brand new PXP?
The discharge of the PXP follows the 2023 launch of Ok Prescription drugs’ flagship product, Aquoral Protecting Oral Spray for Dry Mouth Reduction. Aquoral, a patented lipid-based formulation, creates a protecting barrier on the oral mucosa that is still intact after consuming or ingesting, making it an efficient complement to current xerostomia therapies.
“Many have described Aquoral as a transformative product, which impressed the event of our new PXP,” mentioned Bennett Blakeman, CEO of Ok Prescription drugs. “Our mission is to make sure communities not must endure from this preventable situation or its typically detrimental systemic results.”
